öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µÚÈý½ÚÓ°Ïì΢ÉúÎïÉú³¤µÄÖ÷ÒªÒòËØ
ζȴÓÁ½¸ö·½ÃæÀ´¿´£º ζÈÉÏÉý£¬·´Ó¦ËÙÂʼӿ죬Éú³¤ËÙÂʼӿ죻ζÈÉÏÉý£¬µ°°×ÖÊ¡¢ºËËá±»ÆÆ»µ¡£Î¢ÉúÎïµÄÉú³¤ÓÐÒ»¸öζȷ¶Î§£¬ÔÚÕâ¸ö·¶Î§ÄÚÓÐÒ»¸öÉú³¤µÄ×îÊÊζÈ¡¢×îµÍζȺÍ×î¸ßζÈ¡£×îÊÊζÈ£º¾ú´úʱ×î¶Ì£¬Éú³¤ËÙÂÊ×î¸ß¡£ÑõÆøרÐÔºÃÑõ¾ú(strict aerobe) £¬ ¼æÐÔÑáÑõ¾ú(facultative aerobe) £¬ ΢ºÃÑõ¾ú(microaerophilic bacteria)£¬ÄÍÑõ¾ú(aerotolerant anaerobe)£¬ÑáÑõ¾ú(anacerobe)¡£ºÃÑõÉúÎïÒòΪÓÐSOD£¬Òò´Ë¾ç¶¾µÄ³¬ÑõÒõÀë×Ó×ÔÓÉ»ù£¨O2•£­ £© ±»Æ绯³É¶¾ÐÔÉԵ͵ÄH2O2 £¬ ÔÚ¹ýÑõ»¯ÇâøµÄ×÷ÓÃÏ£¬H2O2 ÔÙ±ä³ÉÎÞ¶¾µÄH2O¡£PH ×îÊÊPH£¬×îµÍPH£¬×î¸ßPH¡£PH µÄÓ°Ï죺ӰÏìÓªÑøÎïµÄÀë×Ó»¯³Ì¶È£¬Ó°Ïì»·¾³ÖÐÓж¾ÎïÖʶÔ΢ÉúÎïµÄ´ÖÐÔ£¬Ó°Ïì´úл·´Ó¦Öи÷ÖÖøµÄ»îÐÔ¡£ »ª¶«Àí¹¤´óѧ¡¶Î¢ÉúÎïѧ½Ì³Ì¡·ÉϿν²ÒåÎïÀíɱ¾úÒòËصĴú±í——ζÈÀûÓøßÎÂɱ¾ú£º¸ÉÈÈÃð¾ú£¨·ÙÉÕÃð¾ú£¬×ÆÉÕÃð¾ú£©£»ÊªÈÈÃð¾ú£¨Öó·ÐÏû¶¾·¨£¬¸ßѹÕôÆûÃð¾ú·¨£¬¼äЪÃð¾ú·¨£¬°Í˹µÂÏû¶¾·¨£© »¯Ñ§É±¾ú¼Á»òÒÖ¾ú¼Á±íÃæÏû¶¾¼Á£¨ÖؽðÊôÑÎÀࣺºì¹¯£» Óлú»¯ºÏÎ·ÓÀà¡¢´¼Àà¡¢ËáÀࡢȩÀࣻÑõ»¯¼Á£ºÂ±Ëؼ°Æ仯ºÏÎ ±íÃæ»îÐÔ¼Á£ºÐ½à¶ûÃ𣬷ÊÔí£»È¾ÁÏ£ºÁúµ¨×Ï£»ÆøÌ壺»·ÑõÒÒÍ飩¡£¿¹´úлҩÎïµÄ´ú±í——»Ç°·ÀàÒ©ÎïµÚËĽÚÓк¦Î¢ÉúÎïµÄ¿ØÖÆÃð¾ú(sterilization)£º²ÉÓÃÇ¿ÁÒµÄÀí»¯ÒòËØʹÈκÎÎïÌåÄÚÍⲿµÄÒ»ÇÐ΢ÉúÎïÓÀԶɥʧÆäÉú³¤·±Ö³ÄÜÁ¦µÄ´ëÊ©£¬³ÆΪÃð¾ú¡£Ïû¶¾(disinfection)£º²ÉÓýÏκ͵ÄÀí»¯ÒòËØ£¬½öɱËÀÎïÌå±íÃæ»òÄÚ²¿Ò»²¿·Ö¶ÔÈËÌå»ò¶¯Ö²ÎïÓк¦µÄ²¡Ô­¾ú£¬¶ø¶Ô±»Ïû¶¾µÄ¶ÔÏó»ù±¾ÎÞº¦µÄ´ëÊ©¡£·À¸¯(antisepsis)£ºÀûÓÃijÖÖÀí»¯ÒòËØÍêÈ«ÒÖÖÆù¸¯Î¢ÉúÎïµÄÉú³¤·±Ö³£¬¼´Í¨¹ýÖƾú×÷Óã¨becteriostasis£©·ÀֹʳƷ¡¢ÉúÎïÖÆÆ·µÈ¶ÔÏó·¢Éúù¸¯µÄ´ëÊ©¡£»¯ÁÆ(chemotherapy)£ºÀûÓþßÓи߶ÈÑ¡Ôñ¶¾Á¦£¨selective toxicity£©¼´¶Ô²¡Ô­¾ú¾ß¸ß¶ÈÑ¡Ôñ¶¾Á¦¶ø¶ÔÆäËÞÖ÷»ù±¾ÎÞ¶¾µÄ»¯Ñ§ÎïÖÊÀ´ÒÖÖÆËÞÖ÷ÌåÄÚ²¡Ô­Î¢ÉúÎïµÄÉú³¤·±Ö³£¬½èÒÔ´ïµ½ÖÎÁƸÃËÞÖ÷´«È¾²¡µÄÒ»ÖÖ´ëÊ©¡£¿¹´úлҩÎïÒ»ÀàÔÚ»¯Ñ§½á¹¹ÉÏÓëϸ°ûÄÚ±ØÒª´úлÎïµÄ½á¹¹ÏàËÆ£¬²¢¿É¸ÉÈÅÆäÕý³£´úл»î¶¯µÄ»¯Ñ§ÎïÖÊ¡£SMZ£º»Ç°·¶þ¼×¶ñßò£¨sulfamethoxazole£©
¿¹ÉúËØÒÖÖÆϸ°û±ÚµÄÐγɣ­ÇàùËØ£¨ÇàùËز»ÄÜ¿Ú·þ£¬Ëü²»ÄÍËᣬÔÚθÖб»½µ½â£©£» Ó°Ïìϸ°ûĤµÄ¹¦ÄÜ£­¶àÕ³¾úËØ£» ¸ÉÈŵ°°×Öʺϳɣ­Á´Ã¹ËØ£» ×è°­ºËËáµÄºÏ³É£­²©À³Ã¹ËØ¡£Î¢ÉúÎïµÄ¿¹Ò©ÐÔ¡£Î¢ÉúÎï¶Ô»·¾³µÄÊÊÓ¦ÐÔ²úÉú¶Û»¯Ã¸£»¸Ä±äϸ°ûĤµÄ͸ÐÔ£»Ï¸°ûÄÚ±»Ò©Îï×÷ÓõIJ¿Î»·¢Éú¸Ä±ä¡£ÀûÓÿ¹Ò©ÐÔÀ´Ö¸µ¼Éú²úÀý£ºÈçºÎÀûÓÿ¹»Ç°·ÀàÒ©ÎïµÄ¾úÖêÉú²ú¶Ô°±»ù±½¼×Ë᣿ »Ç°·¶Ô°±»ù±½¼×ËáÈç¹û¶Ô°±»ù±½¼×ËáÔö¼Ó£¬»Ç°·Ò©ÁÆЧ½µµÍ£¬ËùÒÔÑ°ÕÒ¿¹»Ç°·Ò©µÄ¾úÖê¾Í¿ÉÔö¼Ó¶Ô°±»ù±½¼×ËáµÄ²úÁ¿¡£µÚ°ËÕÂ΢ÉúÎïµÄÒÅ´«±äÒìºÍÓýÖÖÒÅ´«ÐÔ£ºÇ×´ú¾ßÓаÑËûËùÓеÄÐÎ×´¸ø×Ó´úµÄÌØÐÔ¡£±äÒìÐÔ£º×Ó´ú¾ßÓиıäÇ×´úÒÅ´«ÐÔ×´µÄÌØÕ÷¡£ÒÅ´«ÐÍ£¨genotype£©£¬±íÐÍ£¨phenotype£©£¬±äÒ죨varition£©£¬Êα䣨modification£©¡£
µÚÒ»½ÚÒÅ´«±äÒìµÄÎïÖÊ»ù´¡Èý¸ö¾­µäʵÑ飺 ת»¯ÊÔÑ飺1928 Ä꣬F. Griffith£¬·ÎÑ×Ë«Çò¾ú£¬ Streptococcus pneumoniae¡£1944 Äê,O.T.Avery DNA RNA µ°°×ÖʶàÌÇDNA+DNA øR¢ò R¢ò R¢ò R¢ò R¢ò ÉÙÁ¿S¢ó - - - ___ ÊɾúÌå¸ÐȾÊÔÑé:1952 Äê,A. D. Hershey£¨ºîϲ£© M. Chase£¨²Ì˹£© ²¡¶¾µÄÖؽ¨ÊÔÑé: 1956 Ä꣬H. Fraenkel-Conrat £¨¸¥ÀÊ¿Ë£­¿µÀÕÍÑ£© ÊɾúÌå¸ÐȾÊÔÑéºÍ²¡¶¾µÄÖؽ¨ÊÔÑéµÄ˵Ã÷ͼ¼ûÏÂÒ³
ëò¡¶¾µÄ·¢ÏÖºÍ˼¿¼£ºµ°°×ÖÊÊÇ·ñÊÇÒÅ´«µÄÎïÖÊ»ù´¡£¿prpsc£¬µ°°×ÖÊÕÛµþ¡£DNA µÄ½á¹¹»ù±¾µ¥Î»ÊǺËÜÕË᣺ºËÌÇ(ÎìÌÇ)£«¼î»ù£«Á×Ëá¡£¼î»ùÓÐËÄÖÖ£ºÏÙàÑßÊ£¨A£©£¬ÄñàÑßÊ£¨G£©£¬ÐØÏÙà×ण¨T£©£¬ °ûà×ण¨C£©¡£µ¥Á´Éϵļî»ù²»ÊÜÅä¶ÔµÄÏÞÖÆ£¬¾ö¶¨ÁËÒÅ´«µÄ¶àÑùÐÔ¡£°ë±£ÁôµÄ×ÔÎÒ¸´ÖƱ£Ö¤ÁËÉúÎïÒÅ´«µÄÏà¶ÔÎȶ¨¡£µÚ¶þ½Ú»ùÒòÍ»±äºÍÓÕ±äÓýÖÖ20 »ùÒòÍ»±ä£¨gene mutation£©£ºÍ»±äϸ°ûµÄÒÅ´«ÎïÖʵķÖ×ӽṹ»òÊýÁ¿·¢Éú¿ÉÒÅ´«µÄ±ä»¯¡£Í»±äµÄÀàÐÍ£º ÓªÑøȱÏÝÐÍ£¨auxotroph£©¾úÖê:Ò°ÉúÐ;úÖê·¢Éú»ùÒòÍ»±ä¶øɥʧºÏ³ÉÒ»ÖÖ»ò¼¸ÖÖÉú³¤Òò×ÓµÄÄÜÁ¦,´Ó¶ø²»ÄÜÔÚ»ù±¾ÅàÑø»ùÉÏÉú³¤µÄ±äÒì¾úÖê¡£¿¹ÐÔÍ»±äÐÍ£¨resistant mutant£©¾úÖê:Ò°ÉúÐ;úÖê·¢Éú»ùÒòÍ»±ä¶ø¶Ôij»¯Ñ§Ò©Îï»òÖÂËÀÎïÀíÒò×Ó²úÉú¿¹ÐԵľúÖê¡£
Ìõ¼þÖÂËÀÍ»±äÐÍ£¨conditional lethal mutant£©¾úÖê:¾úÖê·¢Éú»ùÒòÍ»±äºó,ÔÚijÖÖÌõ¼þÏ¿ÉÕý³£Éú³¤£¬¶øÔÚÁíÒ»ÖÖÌõ¼þÏÂÎÞ·¨Éú³¤¡£ÐÎ̬ͻ±äÐÍ£¨morphological mutant£©¾úÖê:¾úÖê·¢Éú»ùÒòÍ»±ä£¬¶øÔÚ¸öÌåÐÎ̬»ò¾úÂäÐÎ̬ÉÏ·¢ÉúÍ»±äµÄ¾úÖê¡£¿¹Ô­Í»±äÐÍ£¨antigenic mutant£©¾úÖê:¾úÖê·¢Éú»ùÒòÍ»±ä£¬¶øÔÚϸ°û¿¹Ô­½á¹¹ÉÏ·¢Éú±äÒìµÄ¾úÖê¡£²úÁ¿Í»±äÐÍ£¨metabolite quantitative mutant£©¾úÖê:¾úÖê·¢Éú»ùÒòÍ»±ä£¬ÔÚ´úл²úÎï²úÁ¿ÉÏÃ÷ÏÔÓбðÓÚԭʼ¾úÖêµÄÍ»±äÖê¡£Õý±äÖ꣨plus-mutant£©£»¸º±äÖ꣨minus-mutant£©¡£Í»±äÂÊ£¨mutation rate£©£ºÒ»¸öϸ°ûÿһÊÀ´úijһÐÔ×´Í»±äµÄ¼¸ÂÊ£»ÈºÌåÖÐÿһÊÀ´ú£¨·ÖÁÑÒ»´Î£©²úÉúÍ»±äµÄ¸öÊý¡£Í»±äÂÊ£º10£­8 »ùÒòÍ»±äµÄÌص㣺 ²»¶ÔÓ¦ÐÔ£ºÍ»±äµÄÐÔ×´ÓëÒýÆðÍ»±äµÄÔ­ÒòÖ®¼äûÓÐÖ±½ÓµÄ¶ÔÓ¦¹Øϵ£» ×Ô·¢ÐÔ£¨10£­6¡«10£­9£©£»Ï¡ÓÐÐÔ£»¶ÀÁ¢ÐÔ£»¿ÉÓÕ±äÐÔ£»Îȶ¨ÐÔ£» ¿ÉÄæÐÔ£º»Ø¸´Í»±ä£¨reverse(back)mutation£©¡£Ö¤Ã÷»ùÒòÍ»±ä×Ô·¢ÐԺͲ»¶ÔÓ¦ÐÔµÄʵÑ飺 ±äÁ¿ÊÔÑé(fluctuation test)£º²¨¶¯ÊÔÑé¡¢áÝáåÊÔÑ飻1943 ÄꣻS. E. Luria£¦ M. Delbruck¡£Í¿²¼ÊÔÑ飺1949 Ä꣬H.B.Newcombe Ӱӡƽ°åÅàÑø·¨(replica plating):1952 Äê,J. Lederberg ΢ÉúÎï²úÉú¿¹Ò©ÐÔµÄ;¾¶£º »ùÒòÍ»±ä¶ø²úÉú¿¹Ò©ÐÔ£» ¿¹Ò©ÐÔÖÊÁ£µÄ»ñµÃ(R Òò×Ó)£» ÉúÀíÉϵÄÊÊÓ¦¡£»ùÒòÍ»±ä¼°Æä»úÖÆ£º ÓÒͼΪͻ±äµÄÀàÐÍ¡£
Óձ䣨induced mutation£©£º ¼î»ùµÄÖû»£¨substitution£©£¬×ª»»£¨transition£©£¬µß»»£¨transversion£©¡£Á½¸öÀý×Ó:ÑÇÏõË᣻5-äåÄòà×à¤(¼î»ùÀàËÆÎïbase analog)¡£ÒÆÂëÍ»±ä(frame-shift mutation phase-shift mutation)

ȾɫÌå»û±ä(chromosomal aberration) ת×ù(transposition)£ºDNA ÐòÁÐͨ¹ý·ÇͬԴÖØ×éµÄ·½Ê½£¬´ÓȾɫÌåijһ²¿Î»×ªÒƵ½Í¬Ò»È¾É«ÌåµÄÁíÒ»²¿Î»»òÆäËüȾɫÌåÉϵÄijһ²¿Î»¡£×ª×ùÒò×Ó(transposable element):¾ßÓÐת×ù×÷ÓòåÈëÐòÁÐ(insertion sequence£¬IS)£»×ª×ù×Ó£¨transposon£¬Tn£©£» ת×ùÊɾúÌå(transposable phage) ×Ô·¢Í»±ä£¨spontaneous mutation£©£ºÓÉ΢ÉúÎï×ÔÉíÓк¦´úл²úÎïÒýÆð£»ÓÉDNA ¸´Öƹý³ÌÖмî»ùÅä¶Ô´íÎóÒýÆð£»Óɱ³¾°·øÉäºÍ»·¾³ÒòËØÒýÆð¡£ÒÅ´«ÃÜÂë¸Ä±äµÄ±íÐÍЧӦ£º
×ÏÍâÏ߶ÔDNA µÄËðÉ˼°ÆäÐÞ¸´×ÏÍâÏß(ultraviolet ray)¶ÔDNA µÄËðÉË£»à×शþ¾ÛÌ壻 ¹â¸´»î×÷ÓÃ(photo reactivation£¬photo restoration) ÇгýÐÞ¸´£¨excision repair£© Í»±äÓëÓýÖÖ×Ô·¢Í»±äÓëÓýÖÖ£¨ Breeding by spontaneous mutation£© ´ÓÉú²úÖÐÓýÖÖ£»¶¨ÏòÅàÓýÓÅÁ¼¾úÖê¡£×ÔȻѡÓýµÄÄ¿µÄ£ºÎ¬³ÖÔ­ÓеIJúÎïµÄºÏ³Éˮƽ(ÎȲú)£»ÓÕ±äºóµÄ¾úÖêȺÌåÖбíÏÖ³ö¸÷ÖÖÉúÀíÌØÐÔÐèÒª´¿»¯¡£ÓÕ±äÓýÖÖ£¨breeding by induced mutation£© ÓÕ±äÓýÖֵļ¸¸ö·½Ïò£ºÌá¸ß²úÁ¿£»¸Ä½ø²úÆ·ÖÊÁ¿£»²úÉúеÄÉúÎï»îÐÔÎïÖÊÓÕ±äÓýÖֵĻù±¾»·½Ú£¨×óͼËùʾ£© ³ö·¢¾úÖê→ÓÕ±ä→³õɸ→¸´É¸→·Å´ó→»ñµÃÓÅÁ¼±äÒìÖê¡£ÓÕ±äÓýÖÖÁ½¸öÖ÷ÒªµÄ»·½Ú£ºÓձ䣨induced mutation£©£»É¸Ñ¡£¨screening£©¡£ÓÕ±äÓýÖÖÖеļ¸¸öÔ­Ôò£º ÓÕ±ä¼ÁµÄÑ¡Ôñ£º¼ò±ãÓÐЧ£» ÓÕ±ä¼ÁµÄÖÖÀࣺÎïÀíÓÕ±ä¼Á£¬»¯Ñ§ÓÕ±ä¼Á£¬Äâ·øÉäÎïÖÊ£¨radiomemetic chemical£©£» ÓÕ±ä¼ÁÁ¿µÄÑ¡Ôñ£º´æ»îÂÊ»òËÀÍöÂÊÇúÏߣ¬¼ÁÁ¿-ÓÕ±äÂÊÇúÏߣ» ³ö·¢¾úÖê(original strain)µÄÑ¡Ôñ£º´¦Àíϸ°ûËù´¦µÄ״̬£¬Ò»°ãΪµ¥æß×ÓÐüÒº£» ±íÐÍÑÓ³Ù(phenotype lag)£ºÒÅ´«ÐÍËäÒÑÍ»±ä,µ«±íÐÍÈ´Òª¾­È¾É«Ì帴ÖÆ¡¢·ÖÀëºÍϸ°ûµÄ·ÖÁѺó²Å±íÏÖ³öÀ´¡£ÀûÓø´ºÏ´¦ÀíµÄЭͬЧӦ£¨synergism£©£»ÀûÓúʹ´ÔìÐÎ̬¡¢ÉúÀíºÍ²úÁ¿Ö®¼äµÄÏà¹ØÖ¸±ê£»Éè¼Æ¸ßЧµÄɸѡ·½·¨£ºÍÆÀíÑ¡Óý¡£Í»±äÖêµÄɸѡ:²úÁ¿Í»±äÖêµÄɸѡ,¿¹Ò©ÐÔÍ»±äÖêµÄɸѡ,ÓªÑøȱÏÝÐ;úÖêµÄɸѡ
ÓªÑøȱÏÝÐÍÍ»±äÖ꣺ҰÉúÐ;úÖ꣨wide type strain£©£»Ô­ÑøÐÍ£¨prototroph£©£» »Ø¸´Í»±äÖ꣨back mutant, reverse mutant£©£»»ù±¾ÅàÑø»ù£¨minimum medium,MM)£» ²¹³äÅàÑø»ù(supplemented medium£¬SM£©£»ÍêÈ«ÅàÑø»ù£¨complete medium£¬CM£©¡£Ç°Ìå1→A→B→C→D→Ç°Ìå2 ;¾¶α β γ ø↑ ↑ ↑ a b c »ùÒòÒ»¸ö»ùÒòÒ»Ìõ¶àëÄÁ´É¸Ñ¡ÓªÑøȱÏÝÐ;úÖêµÄËĸö»·½Ú£º Óձ䣻ÌÔÌ­Ò°ÉúÐÍ£¨¿¹ÉúËØ·¨£¬¾úË¿¹ýÂË·¨£©£»¼ì³öȱÏÝÐÍ£¨¼Ð²ãÅàÑø·¨£¬ÏÞÁ¿²¹³ä·¨£¬Öð¸ö¼ì³ö·¨£¬Ó°Ó¡Æ½°å·¨£©£»¼ø¶¨È±ÏÝÐÍ£¨Éú³¤Æ×·¨£©¡£Î¬ÉúËصÄÉú³¤Æ×ÓªÑøȱÏÝÐ;úÖêµÄÓ¦ÓãºÀµ°±ËᣬÑо¿´úл;¾¶¡£°±»ùËáµÄÉú³¤Æ×
Ñо¿´úл;¾¶£º ´Ö²ÚÁ´æßù£¨Neurospora crassa£© ¹Ï°±Ëᣭ £« £« Äñ°±Ëᣭ £­ £« Í»±äÖê¢ñ Í»±äÖê¢ò Í»±äÖê¢ó ¾«°±Ëᣫ £« £« Ç°Ìå→Äñ°±Ëá→¹Ï°±Ëá→¾«°±Ëá→.. °¬Ä·ÊÏÊÔÑé(Ames test)£ºÉúÎïµÄÒÅ´«ÎïÖÊÊǺËË᣻·²¶Ô΢ÉúÎïÓÐЧµÄÓÕ±ä¼Á¶Ô¸ßµÈ¶¯ÎïͬÑùÓÐЧ£»»¯Ñ§Ò©¼Á¶Ôϸ¾úµÄÓÕ±äÂÊÓëÆä¶Ô¶¯ÎïµÄÖ°©ÂʳÉÕý±È£»·²Ö°©ÎïÖʶ¼ÊÇÓÕ±ä¼Á£¬µ«²¢·ÇËùÓеÄÓÕ±ä¼Á¶¼ÄÜÖ°©£»95£¥µÄÖ°©¼ÁÓÐÓÕ±ä×÷Ó㬠Լ90£¥µÄ·ÇÖ°©¼Á¾ÍûÓÐÓÕ±ä¼ÁµÄ×÷ÓᣲÄÁÏ£ºÊóÉ˺®É³ÃÅÊϾú×é°±ËáȱÏÝÐ;úÖ꣬ÀÏÊó¸ÎÔà³éÌáÒº¡£
µÚÈý½Ú»ùÒòÖØ×éºÍ»ùÒòÔÓ½»»ùÒòÖØ×é(gene recombination) ÒÅ´«ÖØ×é(genetic recombination)£ºÁ½¸ö¶ÀÁ¢»ùÒò×éÄÚµÄÒÅ´«»ùÒò£¬Í¨¹ýÒ»¶¨µÄ;¾¶×ªÒƵ½Ò»Æð£¬ÐγÉеÄÎȶ¨»ùÒò×éµÄ¹ý³Ì¡£Ô­ºËÉúÎïµÄ»ùÒòÖØ×éת»¯(transformation) תµ¼(transduction) ½ÓºÏ(conjugation, mating) Ô­ÉúÖÊÌåÈÚºÏ(protoplast fusion) ת»¯£ºÊÜÌå¾úÖ±½ÓÎüÊÕÀ´×Ô¹©Ìå¾úµÄDNA Ƭ¶Î£¬Í¨¹ý½»»»°ÑËûÕûºÏµ½×Ô¼ºµÄ»ùÒò×éÖУ¬´Ó¶ø»ñµÃ¹©Ìå¾ú²¿·ÖÒÅ´«ÐÔ×´µÄÏÖÏó¡£ÊÜÌåϸ°û£¨recipient cell, receptor£© ¹©Ìåϸ°û£¨donor cell£© ת»¯×Ó£¨transformant£©
¸ÐÊÜ̬£ºÊÜÌåϸ°û×îÒ×½ÓÊÜÍâÔ´DNA Ƭ¶Î²¢ÊµÏÖת»¯µÄÉúÀí״̬¡£×ª»¯µÄ¹ý³Ì£º¸ÐÊÜ̬ϸ°ûÎüÊÕDNA£»DNA ²ôÈëϸ°ûºóµÄÕûºÏ¡£×ª»¯µÄÒªÇó£ºÊÜÌåϸ°û´¦ÓÚ¸ÐÊÜ״̬£¨competence£© ת»¯µÄÌص㣺ֱ½ÓÎüÊÕ£»ÊÜÌåϸ°û´¦ÓÚ¸ÐÊÜ̬תȾ£¨transfection£© תµ¼£ºÍ¨¹ýȱÏÝÊɾúÌåµÄý½é£¬½«¹©Ìåϸ°ûµÄDNA Ƭ¶ÎЯ´øÈëÊÜÌåϸ°ûÖУ¬Í¨¹ý½»»»ºÍÕûºÏ£¬ ʹºóÕß»ñµÃÇ°ÕߵIJ¿·ÖÒÅ´«ÐÔ×´¡£È±ÏÝÊɾúÌ壨defective phage£© תµ¼×Ó£¨transductant£© ÆÕ±éÐÔתµ¼£¨generalized transduction£©£ºÍêȫȱÏÝÊɾúÌå¡£Ìص㣺Ëæ»ú°ü¹ü£»×ªµ¼×Ó·ÇÈÜÔ­ÐÔ¡£¾ÖÏÞÐÔתµ¼£¨specialized transduction£©£º²¿·ÖȱÏÝÊɾúÌå¡£Ìص㣺תµ¼µÄÊÇÌض¨»ùÒò£»×ªµ¼×ÓΪȱÏÝÈÜÔ­ÐÔ¡£ÆÕ±éÐÔתµ¼ºÍ¾ÖÏÞÐÔתµ¼µÄ±È½ÏÆÕ±éÐÔתµ¼ºÍ¾ÖÏÞÐÔתµ¼µÄ±È½ÏÆÕ±éתµ¼ÈκλùÒòÄÜתµ¼µÄ»ùÒò²»½áºÏµ½¼ÄÖ÷ÉÏÊɾúÌåÔÚ¼ÄÖ÷ÖеÄλÖûñµÃת»¯ÊɾúÌåµÄ·½Ê½×ªµ¼×ÓµÄÇø±ðͨ¹ýÃô¸Ð¾úµÄÁѽâ·ÇÈÜÔ­ÐÔÌض¨»ùÒò½áºÏµ½¼ÄÖ÷ÉÏͨ¹ýÈÜÔ´¾úµÄÓÕµ¼²¿·ÖÈÜÔ­ÐÔ
ÈÜԴת±älysogenic conversion ½ÓºÏ£º¹©Ìå¾ú£¨F£«¾úÖ꣬ÐÛÐÔ¾úÖ꣩ͨ¹ýÐÔ¾úëÓëÊÜÌå¾ú£¨F-¾úÖ꣬´ÆÐÔ¾úÖֱ꣩½Ó½Ó´¥£¬°ÑF ÖÊÁ£»òÆäЯ´øµÄ²»Í¬³¤¶ÈµÄºË»ùÒò×éƬ¶Î´«µÝ¸øºóÕߣ¬Ê¹ºóÕß»ñµÃÈô¸ÉеÄÒÅ´«ÐÔ×´¡£F+¾úÖꣻF-¾úÖꣻHfr ¾úÖꣻF’¾úÖê¡£Ìص㣺Á½Ï¸°ûÖ±½Ó½Ó´¥£»ÐèÒªÐÔÒò×ÓÐÔÒò×Ó¿Éͨ¹ý½ÓºÏ»ñµÃ¡£Ô­ÉúÖÊÌåÈںϣºÍ¨¹ýÈ˹¤µÄ·½·¨£¬Ê¹ÒÅ´«ÐÔ×´²»Í¬µÄÁ½¸öϸ°ûµÄÔ­ÉúÖÊÌå½øÐÐÈںϣ¬´Ó¶ø»ñµÃ¼æÓÐÁ½Ç×±¾ÒÅ´«ÐÔ×´µÄÖØ×é×Ó¡£Ô­ÉúÖÊÌå¼¼ÊõµÄÓÅÔ½ÐÔ£ºÈ¥µôÁËϸ°û±ÚµÄÕÏ°­£¬Ç×Öê»ùÒò×é¿ÉÖ±½ÓÈںϡ¢½»»»£¬²¢ÎªÁ´Ã¹¾úʵÏÖ»ùÒòת»¯´´ÔìÁËÌõ¼þ£»¶þÇ×ÖêµÄ»ùÒò×éÖ®¼ä¿É·¢Éú¶à´Î½»»»£¬µÃµ½¶àÖÖÀàÐ͵ÄÖØ×é×Ó£¬ ÇÒ²ÎÓëÈںϵÄÇ×Öê²»ÏÞÓÚÒ»¸ö£¬¿ÉÒÔ¶àÖÁ3¡¢4 ¸ö£»ÖØ×éƵÂʸߣ»¿ÉÓÃÓÕ±äµÄ·½·¨Ö±½Ó´¦ÀíÔ­ÉúÖÊÌ壬Ìá¸ßÍ»±äÂÊ£»ÔÙÉú³Éϸ°û±ÚµÄ¹ý³Ì³£°éËæÖÎÀíµÄÏû³ý£¬Ê¹È¾É«Ìå·¢Éú¸Ä±ä£»¼«Æä¼òµ¥£¬²Ù×÷·½±ã£¬²»ÐèÒª¹óÖØÒ©Æ·¡£
ÈçºÎµÃµ½Ô­ÉúÖÊÌ壺¾úÌ壨¾úË¿£©ÅàÑø£»Ï¸°û±ÚµÄÈ¥³ý£»Ô­ÉúÖÊÌåµÄÈںϣ¨ÔÙÉú£©£» ¼ì³öÖØ×é×Ó¡£ÔÙÉúƵÂʵļÆË㣺 Ô­ÉúÖÊÌåÊýH£­Ô­ÉúÖÊÌåÊýË®ÔÙÉúƵÂÊ£½———————————— Ô­ÉúÖÊÌå×ÜÊý£¨ÑªÇò¼ÆÊý£© Ô­ÉúÖÊÌå¼¼ÊõµÄÓ¦ÓãºÀûÓÃÔ­ÉúÖÊÌåÐγɼ°ÔÙÉú´ïµ½¸ÄÁ¼Ç×±¾µÄÄ¿µÄ£¨´ó»·ÄÚõ¥À࿹ÉúËØ£©£»ÀûÓÃÔ­ÉúÖÊÌåÓÕ±äÌá¸ßÍ»±äÂÊ£¨Çì´óùËØ£©£»ÀûÓÃÔ­ÉúÖÊÌåÈںϻñµÃÐԵĿ¹ÉúËØ£¨Indolizomycin£©£»ÀûÓÃÔÙÉú£¬µÃµ½Á˲úÁ¿Ìá¸ßµÄ±äÒì¾úÖ꣬ÀýÈçÉú¶þËØÁ´Ã¹¾ú£¨Streptomytece ambofaciens£©Í¨¹ýÔ­ÉúÖÊÌåÔÙÉú£¬ÂÝÐýùËصÄÉú²úÄÜÁ¦Ìá¸ßÁËÈý±¶¶à¡£ÖÊÁ£Ïû³ýµÄ½á¹û³£³£µ¼ÖÂϸ°ûȾɫÌåµÄ¸Ä±ä£¬»òʹ´Î¼¶´úл;¾¶·¢Éú±ä»¯(°×ùËغͽð˿ùËØ)£¬³öÏÖÓÐÀûÓÚÌá¸ß¿¹ÉúËزúÁ¿µÄ±äÒì¾úÖê¡£ÓÐЧµÄÖÖ¼äÈںϣ¬Ê¹Á½¸ö²úÉú²»Í¬¿¹ÉúËؾúÖêµÄµ÷½Ú»ùÒòºÍ½á¹¹»ùÒòÖØ×éÔÚÒ»Æð£¬ÓÕ·¢Ò»Ð©Ô­À´Îª“³ÁĬ»ùÒò’µÄ±í´ï£¬´Ó¶ø²úÉúÐÂÎïÖÊ¡£Í¬Ê±ÖÖ¼äÈںϻ¹¿ÉÄÜʹÁ½¸ö²úÉú²»Í¬¿¹ÉúËؾúÖêµÄ½á¹¹»ùÒòÖØ×é¶ø²úÉúÔÓÖÖ¿¹ÉúËØ¡£ÕæºË΢ÉúÎïµÄ»ùÒòÖØ×éÓÐÐÔÔÓ½»£¨sexual hybridization£© ×¼ÐÔÔÓ½»£¨parasexual hybridization£© ͬÖÖ¶ø²»Í¬¾úÖêµÄÌåϸ°û¼ä·¢ÉúµÄÈںϣ¬³£¼ûÓÚ°ëÖª¾úÀà¡£×¼ÐÔÔÓ½»¹ý³Ì£º¾úË¿Áª½á£¨anastomosis£©£»ÐγÉÒìºËÌ壨heterocaryon£©£»ºËÈںϣ¨nuclear fusion£©£»Ìåϸ°û½»»»£¨somatic crossing-over£©ºÍµ¥±¶»¯¡£µÚËĽڻùÒò¹¤³Ì»ùÒò¹¤³Ì(gene engineering) ÒÅ´«¹¤³Ì£¨genetic eng ineering£©£ºÈ˹¤µÄÀëÌåµÄ·Ö×ÓˮƽÉϵÄÒÅ´«ÖØ×é¼¼Êõ¡£»ù±¾²Ù×÷£º»ñÈ¡Ä¿µÄ»ùÒò£»ÓÅÁ¼ÔØÌåµÄÑ¡Ôñ£» Ä¿µÄ»ùÒòÓëÔØÌåDNA µÄÌåÍâÖØ×飻ÖØ×éÔØÌåµ¼ÈëÊÜÌåϸ°û£¨×ª»¯£©£»ÖØ×éÊÜÌåϸ°ûµÄɸѡºÍ¼ø¶¨£»¹¤³Ì¾úµÄ±í